Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    16020506 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed QUIREDEX: Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression
Condition: Multiple Myeloma
Intervention: Procedure: Maintenance with lower doses of lenalidomide and dexamethasone

Study has passed its completion date and status has not been verified in more than two years.